Publication | Open Access

Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non–nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group

Neck CancerOncologyMedicineCancer ManagementLiposomal DoxorubicinMolecular OncologyCost AnalysisHead And Neck CancerCancer TreatmentNeck OncologyRadiation OncologyPharmacologyCancer TherapeuticsCancer ResearchOral CancerHealth Sciences